Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.97 USD | +1.56% | +0.08% | +14.61% |
14/03 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
13/03 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.61% | 375M | |
-3.69% | 86.13B | |
+1.97% | 39.82B | |
+56.59% | 25.23B | |
-14.82% | 15.36B | |
-8.82% | 11.95B | |
-16.29% | 11.6B | |
-41.58% | 11.51B | |
+6.14% | 8.71B | |
-8.65% | 8.12B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Sector Update: Health Care